IGI Laboratories has partnered with DDN, a provider of outsourced business services to the life science industry, for the launch of its first IGI-labeled generic products later this year. DDN will provide product launch support, logistics support and order to cash services.
Jason Grenfell-Gardner, president and chief executive officer of IGI, said, “Our partnership with DDN completes a significant step in our go-to-market strategy, and we are extremely pleased to have DDN as a partner to help guide us through the logistics regarding the launch of our first IGI labeled products later this year. As I have mentioned, there were several steps in the execution of our go to market strategy, and now with DDN in place, IGI can focus on aggressively selling and marketing our IGI label products.”
DDN president Mark Wiesman said, “We look forward to providing support to IGI as they launch their products into the marketplace. Our goal is to provide broad expertise and scalable infrastructure to life science companies such as IGI, allowing them to focus their attention and capital on rapidly growing their business. We look forward to partnering with IGI as together we provide outstanding service to their customers.”